Pharmacovigilance of herbal products in India

Journal of Young Pharmacists

Volumn 3, Issue 3, 2011, Pages 256-258

  Wal, P ^a   Wal, A ^a   Gupta, S ^a   Sharma, G ^a   Rai, A K ^a  

^a PRANVEER SINGH INSTITUTE OF TECHNOLOGY   (India)

Author keywords

Adverse reaction; Herbal medicines; Pharmacovigilance

Indexed keywords

AYURVEDIC DRUG; GINKGO BILOBA EXTRACT; HERBACEOUS AGENT; INTERFERON;

ADVERSE DRUG REACTION; ARTICLE; AYURVEDA; BRAIN HEMORRHAGE; CHINESE MEDICINE; CORTICOSTEROID LIKE DISEASE; DRUG CONTAMINATION; DRUG INDUCED DISEASE; DRUG POTENTIATION; DRUG QUALITY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; HEMATOMA; HERBAL MEDICINE; HOMEOPATHY; HUMAN; INDIA; INDUSYNUNIC MEDICINE; INTERSTITIAL PNEUMONIA; ISLAMIC MEDICINE; KIDNEY FAILURE; PRIORITY JOURNAL; TRADITIONAL MEDICINE;

EID: 80051870279     PISSN: 09751483     EISSN: 09751505     Source Type: Journal    
DOI: 10.4103/0975-1483.83780     Document Type: Article

References (9)

1. WHO guidelines on safety monitoring of herbal medicines in pharmacovigilance systems. World Health Organization: Geneva; 2004. p.19.
2. Williamson E. Drug interactions between herbal and prescription medicines. Drug Saf 2003;26:1075-92. (Pubitemid 38021390)
3. Jordan SA, Cunningham DG, Marles RJ. Assessment of herbal medicinal products: Challenges, and opportunities to increase the knowledge base for safety sassessment. Toxicol Appl Pharmacol 2010;243:198-216.
4. Health Canada, 2009a. Release of the guidance document for industry-reporting adverse reactions to marketed health products. July 09, 2009. Available from: http://www.hc-sc.gc.ca/dhp-mps/pubs/medeff/-guide/2009- guidance-directrice-reporting-notification/index-eng.php. [last accessed on 2009 Sep 28].
5. Farah MH, Edwards R, Lindquist M, Leon C, Shaw D. International monitoring of adverse health effects associated with herbal medicines. Pharmacoepidemiol Drug Saf 2000;9:105-12. (Pubitemid 30307351)
6. Gardiner P, Sarma DN, Dog TL, Barrett ML, Chavez ML, Ko R, et al. The state of dietary supplement adverse event reporting in the United States.Pharmacoepidemiol Drug Saf 2008;17:962-70.
7. Health Canada, 2006. Reporting adverse reactions for naturopathic doctors. Available from: http://www.hc-sc.gc.ca/dhp-mps/medeff/centre-learn- appren/nd-dn-ar-ei-module-eng.php. [last accessed on 2009 Sep 23].
8. Farah MH, Olsson S, Bate J, Lindquist M, Edwards R, Simmonds MS, et al. Botanical nomenclature in pharmacovigilance and a recommendation for standardisation. Drug Saf 2006;29:1023-9. (Pubitemid 44912711)
9. But PP, Atherton DJ, Rustin MH, Brostoff J. Need for correct identification of herbs in herbal poisoning. Lancet 1993;341:637-8. (Pubitemid 23066190)